Clinical trials
Colorectal Neoplasms trials in the United Kingdom with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2004 | 2 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 8 |
| London North West Healthcare NHS Trust | 4 |
| Cambridge University Hospitals NHS Foundation Trust | 2 |
| Imperial College London | 2 |
| King's College Hospital NHS Trust | 2 |
| Medical Research Council | 2 |
| South Tyneside and Sunderland NHS Foundation Trust | 2 |
| University of Manchester | 2 |
| University of Oxford | 2 |
| University of Southampton | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colorectal Neoplasms | 61 |
| Rectal Neoplasms | 18 |
| Colonic Neoplasms | 15 |
| Neoplasms | 8 |
| Intestinal Neoplasms | 5 |
| Neoplasm Metastasis | 5 |
| Adenoma | 4 |
| Adenocarcinoma | 3 |
| Adenocarcinoma, Mucinous | 3 |
| Breast Neoplasms | 3 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.